Physician profile
Sanjay Razdan
NPI 1518921865
$20,547.81
in general payments reported to CMS, 2019-2025
39 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,083 · 2020: $576 · 2021: $917 · 2022: $835 · 2023: $1,007 · 2024: $2,020 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,000 · Food and Beverage: $6,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,000.00 |
| Food and Beverage | $6,137.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $9,242.16 | 2025 | |
| Metuchen Pharmaceuticals | $2,644.24 | 2019-2020 | |
| Mimedx Group, INC. | $2,598.46 | 2024-2025 | |
| Boston Scientific Corporation | $1,606.31 | 2019-2025 | Ams 700, Rezum Generator, General - Erectile Dysfunction |
| Intuitive Surgical, INC. | $607.20 | 2021-2024 | Da Vinci Surgical System |
| Coloplast Corp | $469.47 | 2019-2025 | |
| Procept Biorobotics Corporation | $447.04 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Olympus America INC. | $352.12 | 2021-2023 | Itind System |
| Sanara Medtech INC. | $301.46 | 2023-2024 | Celleraterx |
| Smith+Nephew, INC. | $222.33 | 2020 | |
| Progenics Pharmaceuticals, INC. | $206.71 | 2024-2025 | |
| Profound Medical Corp. | $204.27 | 2023-2025 | Tulsa-Pro |
| Biotissue Holdings INC. | $174.43 | 2020-2023 | |
| Astellas Pharma US INC | $172.60 | 2019-2022 | |
| Davol INC. | $141.66 | 2022-2023 | Arista Ah Flexitip, Phasix Mesh |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Razdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.